By Zhian Chen and Di Yu

PMID: 35355007

Context-dependent functions of pattern recognition receptors in cancer.

Man SM, Jenkins BJ.

Nat Rev Cancer. 2022 Jul;22(7):397-413. doi: 10.1038/s41568-022-00462-5. Epub 2022 Mar 30.PMID: 35355007 Review.


PMID: 35790881

IL-17 and IL-17-producing cells in protection versus pathology.

Mills KHG.

Nat Rev Immunol. 2022 Jul 5:1-17. doi: 10.1038/s41577-022-00746-9. Online ahead of print.PMID: 35790881 Free PMC article. Review.


PMID: 35650271

Role of thymic stromal lymphopoietin in allergy and beyond.

Ebina-Shibuya R, Leonard WJ.

Nat Rev Immunol. 2022 Jun 1:1-14. doi: 10.1038/s41577-022-00735-y. Online ahead of print.PMID: 35650271 Free PMC article. Review.


PMID: 35879417

Mitochondrial control of inflammation.

Marchi S, Guilbaud E, Tait SWG, Yamazaki T, Galluzzi L.

Nat Rev Immunol. 2022 Jul 25:1-15. doi: 10.1038/s41577-022-00760-x. Online ahead of print.PMID: 35879417 Free PMC article. Review.


PMID: 35217787

Engineering IL-2 for immunotherapy of autoimmunity and cancer.

Hernandez R, Põder J, LaPorte KM, Malek TR.

Nat Rev Immunol. 2022 Feb 25. doi: 10.1038/s41577-022-00680-w. Online ahead of print.PMID: 35217787 Review.


PMID: 35354980

Heterogeneity of type 2 innate lymphoid cells.

Spits H, Mjösberg J.

Nat Rev Immunol. 2022 Mar 30:1-12. doi: 10.1038/s41577-022-00704-5. Online ahead of print.PMID: 35354980 Free PMC article. Review.


PMID: 35322259

The role of PI3Kγ in the immune system: new insights and translational implications.

Lanahan SM, Wymann MP, Lucas CL.

Nat Rev Immunol. 2022 Mar 23. doi: 10.1038/s41577-022-00701-8. Online ahead of print.PMID: 35322259 Review.


PMID: 35246670

Inflammation and immune dysfunction in Parkinson disease.

Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V.

Nat Rev Immunol. 2022 Mar 4:1-17. doi: 10.1038/s41577-022-00684-6. Online ahead of print.PMID: 35246670 Free PMC article. Review.


PMID: 35277664

The link between circulating follicular helper T cells and autoimmunity.

Walker LSK.

Nat Rev Immunol. 2022 Mar 11:1-9. doi: 10.1038/s41577-022-00693-5. Online ahead of print.PMID: 35277664 Free PMC article. Review.


PMID: 35729334

IL-1 and autoinflammatory disease: biology, pathogenesis and therapeutic targeting.

Broderick L, Hoffman HM.

Nat Rev Rheumatol. 2022 Aug;18(8):448-463. doi: 10.1038/s41584-022-00797-1. Epub 2022 Jun 21.PMID: 35729334 Free PMC article. Review.


PMID: 35817844

Targeting TFH cells in human diseases and vaccination: rationale and practice.

Yu D, Walker LSK, Liu Z, Linterman MA, Li Z.

Nat Immunol. 2022 Jul 11. doi: 10.1038/s41590-022-01253-8. Online ahead of print.PMID: 35817844 Review.


PMID: 35241833

A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance.

Huang AC, Zappasodi R.

Nat Immunol. 2022 May;23(5):660-670. doi: 10.1038/s41590-022-01141-1. Epub 2022 Mar 3.PMID: 35241833 Free PMC article. Review.



PMID: 35691784

Biogenesis and engineering of interleukin 12 family cytokines.

Hildenbrand K, Aschenbrenner I, Franke FC, Devergne O, Feige MJ.

Trends Biochem Sci. 2022 Jun 9:S0968-0004(22)00138-4. doi: 10.1016/j.tibs.2022.05.005. Online ahead of print.PMID: 35691784 Review.


PMID: 35277286

Selective tyrosine kinase 2 inhibitors in inflammatory bowel disease.

Nielsen OH, Boye TL, Chakravarti D, Gubatan J.

Trends Pharmacol Sci. 2022 May;43(5):424-436. doi: 10.1016/ Epub 2022 Mar 8.PMID: 35277286 Review.


PMID: 35570161

IL-33-ILC2 axis in the female reproductive tract.

Miller JE, Koti M, Tayade C.

Trends Mol Med. 2022 Jul;28(7):569-582. doi: 10.1016/j.molmed.2022.04.006. Epub 2022 May 12.PMID: 35570161 Review.


PMID: 35492880

Harnessing the chemokine system to home CAR-T cells into solid tumors.

Foeng J, Comerford I, McColl SR.

Cell Rep Med. 2022 Feb 28;3(3):100543. doi: 10.1016/j.xcrm.2022.100543. eCollection 2022 Mar 15.PMID: 35492880 Free PMC article. Review.


PMID: 35753845

Toll-like receptor-mediated neuroinflammation: relevance for cognitive dysfunctions.

Squillace S, Salvemini D.

Trends Pharmacol Sci. 2022 Jun 23:S0165-6147(22)00127-4. doi: 10.1016/ Online ahead of print.PMID: 35753845 Review.


PMID: 35501268

Utilizing chemokines in cancer immunotherapy.

Märkl F, Huynh D, Endres S, Kobold S.

Trends Cancer. 2022 Aug;8(8):670-682. doi: 10.1016/j.trecan.2022.04.001. Epub 2022 Apr 29.PMID: 35501268 Review.


PMID: 35513901

NLRP3 and pyroptosis blockers for treating inflammatory diseases.

Coll RC, Schroder K, Pelegrín P.

Trends Pharmacol Sci. 2022 Aug;43(8):653-668. doi: 10.1016/ Epub 2022 May 3.PMID: 35513901 Free article. Review.


PMID: 35624009

Therapeutic potential of interleukin-2 in autoimmune diseases.

Yuan Y, Kolios AGA, Liu Y, Zhang B, Li H, Tsokos GC, Zhang X.

Trends Mol Med. 2022 Jul;28(7):596-612. doi: 10.1016/j.molmed.2022.04.010. Epub 2022 May 24.PMID: 35624009 Review.


PMID: 35302863

Transforming growth factor-β1 in regulatory T cell biology.

Moreau JM, Velegraki M, Bolyard C, Rosenblum MD, Li Z.

Sci Immunol. 2022 Mar 18;7(69):eabi4613. doi: 10.1126/sciimmunol.abi4613. Epub 2022 Mar 18.PMID: 35302863 Review.


PMID: 35306673

Mechanisms of immune regulation by the placenta: Role of type I interferon and interferon-stimulated genes signaling during pregnancy.

Ding J, Maxwell A, Adzibolosu N, Hu A, You Y, Liao A, Mor G.

Immunol Rev. 2022 Jul;308(1):9-24. doi: 10.1111/imr.13077. Epub 2022 Mar 20.PMID: 35306673 Review.


PMID: 35656941

Unique aspects of IFN-γ/STAT1 signaling in neurons.

Clark DN, Begg LR, Filiano AJ.

Immunol Rev. 2022 Jun 3. doi: 10.1111/imr.13092. Online ahead of print.PMID: 35656941 Review.


PMID: 35039323

Cutaneous signs and mechanisms of inflammasomopathies.

Borst C, Symmank D, Drach M, Weninger W.

Ann Rheum Dis. 2022 Apr;81(4):454-465. doi: 10.1136/annrheumdis-2021-220977. Epub 2022 Jan 17.PMID: 35039323 Review.


PMID: 35732818

Critical roles of G protein-coupled receptors in regulating intestinal homeostasis and inflammatory bowel disease.

Feng Z, Sun R, Cong Y, Liu Z.

Mucosal Immunol. 2022 Jun 22. doi: 10.1038/s41385-022-00538-3. Online ahead of print.PMID: 35732818 Review.


PMID: 35902046

Emerging role of the cGAS-STING signaling pathway in autoimmune diseases: Biologic function, mechanisms and clinical prospection.

Hu Y, Chen B, Yang F, Su Y, Yang D, Yao Y, Wang S, Wu Y, Tao L, Xu T.

Autoimmun Rev. 2022 Jul 25;21(9):103155. doi: 10.1016/j.autrev.2022.103155. Online ahead of print.PMID: 35902046 Review.


PMID: 35595051

Significance of IL-7 and IL-7R in RA and autoimmunity.

Meyer A, Parmar PJ, Shahrara S.

Autoimmun Rev. 2022 Jul;21(7):103120. doi: 10.1016/j.autrev.2022.103120. Epub 2022 May 17.PMID: 35595051 Review.


COVID-19 special collection

PMID: 35788185

Considering innate immune responses in SARS-CoV-2 infection and COVID-19.

Diamond MS, Lambris JD, Ting JP, Tsang JS.

Nat Rev Immunol. 2022 Aug;22(8):465-470. doi: 10.1038/s41577-022-00744-x. Epub 2022 Jul 4.PMID: 35788185 Free PMC article.


PMID: 35304596

SARS-CoV-2 infection and COVID-19 vaccination in pregnancy.

Male V.

Nat Rev Immunol. 2022 May;22(5):277-282. doi: 10.1038/s41577-022-00703-6. Epub 2022 Mar 18.PMID: 35304596 Free PMC article. Review.


PMID: 35484322

Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?

Kent SJ, Khoury DS, Reynaldi A, Juno JA, Wheatley AK, Stadler E, John Wherry E, Triccas J, Sasson SC, Cromer D, Davenport MP.

Nat Rev Immunol. 2022 Jun;22(6):387-397. doi: 10.1038/s41577-022-00716-1. Epub 2022 Apr 28.PMID: 35484322 Free PMC article. Review.


PMID: 35277694

COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety.

Fendler A, de Vries EGE, GeurtsvanKessel CH, Haanen JB, Wörmann B, Turajlic S, von Lilienfeld-Toal M.

Nat Rev Clin Oncol. 2022 Jun;19(6):385-401. doi: 10.1038/s41571-022-00610-8. Epub 2022 Mar 11.PMID: 35277694 Free PMC article. Review.


PMID: 35354968

SARS-CoV-2 pathogenesis.

Lamers MM, Haagmans BL.

Nat Rev Microbiol. 2022 May;20(5):270-284. doi: 10.1038/s41579-022-00713-0. Epub 2022 Mar 30.PMID: 35354968 Review.


PMID: 35637104

Instructing durable humoral immunity for COVID-19 and other vaccinable diseases.

Bhattacharya D.

Immunity. 2022 Jun 14;55(6):945-964. doi: 10.1016/j.immuni.2022.05.004. Epub 2022 May 10.PMID: 35637104 Free PMC article. Review.


PMID: 35277325

COVID-19 in pregnancy: implications for fetal brain development.

Shook LL, Sullivan EL, Lo JO, Perlis RH, Edlow AG.

Trends Mol Med. 2022 Apr;28(4):319-330. doi: 10.1016/j.molmed.2022.02.004. Epub 2022 Feb 14.PMID: 35277325 Free PMC article. Review.


PMID: 35810128

Olfactory dysfunction in COVID-19: pathology and long-term implications for brain health.

Doty RL.

Trends Mol Med. 2022 Jun 20:S1471-4914(22)00160-5. doi: 10.1016/j.molmed.2022.06.005. Online ahead of print.PMID: 35810128 Free PMC article. Review.


PMID: 35697684

Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19.

Li X, Zhang Z, Wang Z, Gutiérrez-Castrellón P, Shi H.

Signal Transduct Target Ther. 2022 Jun 13;7(1):186. doi: 10.1038/s41392-022-01043-6.PMID: 35697684 Free PMC article. Review.


PMID: 35775361

Interferon induction, evasion, and paradoxical roles during SARS-CoV-2 infection.

Chiale C, Greene TT, Zuniga EI.

Immunol Rev. 2022 Aug;309(1):12-24. doi: 10.1111/imr.13113. Epub 2022 Jul 1.PMID: 35775361 Free PMC article. Review.


PMID: 35597182

Trained immunity: implications for vaccination.

Geckin B, Konstantin Föhse F, Domínguez-Andrés J, Netea MG.

Curr Opin Immunol. 2022 Aug;77:102190. doi: 10.1016/j.coi.2022.102190. Epub 2022 May 18.PMID: 35597182 Free article. Review.


Bronze Sponsor of Cytokines 2022 Hybrid Meeting